Comment in

• Commentary: on the incidence of histological prostate cancer and the probable diagnosis of cases with tumours too small to produce symptoms or to attract attention on physical examination--the findings of Dr Arnold Rice Rich.

  Adolfsson J. Adolfsson J. Int J Epidemiol. 2007 Apr;36(2):285-7. doi: 10.1093/ije/dym053. Epub 2007 Apr 17. Int J Epidemiol. 2007. PMID: 17440029 No abstract available.
• Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: "what has been will be again, what has been done will be done again; there is nothing new under the sun." ECCLESIASTES 1:9.

  Thompson IM, Lucia MS, Tangen CM. Thompson IM, et al. Int J Epidemiol. 2007 Apr;36(2):287-9. doi: 10.1093/ije/dym056. Epub 2007 Apr 23. Int J Epidemiol. 2007. PMID: 17452387 No abstract available.
• Commentary: prostate cancer is omnipresent, but should we screen for it?

  Martin RM. Martin RM. Int J Epidemiol. 2007 Apr;36(2):278-81. doi: 10.1093/ije/dym049. Int J Epidemiol. 2007. PMID: 17567642 Free PMC article. No abstract available.
• Commentary: occult prostate cancer--imposter or the real deal?

  Albertsen PC. Albertsen PC. Int J Epidemiol. 2007 Apr;36(2):281-2. doi: 10.1093/ije/dym051. Int J Epidemiol. 2007. PMID: 17567643 No abstract available.
• Commentary: implications of the frequent occurrence of occult carcinoma of the prostate.

  Miller AB. Miller AB. Int J Epidemiol. 2007 Apr;36(2):282-4. doi: 10.1093/ije/dym052. Int J Epidemiol. 2007. PMID: 17567644 No abstract available.